Legend Biotech Corporation
LEGN
$19.66
-$0.25-1.26%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -91.60M | -250.20M | -296.90M | -239.78M | -325.41M |
| Total Depreciation and Amortization | 45.15M | 39.25M | 28.75M | 23.18M | 21.21M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 116.67M | 224.77M | 262.17M | 152.77M | 218.56M |
| Change in Net Operating Assets | -159.62M | -95.52M | -94.22M | -106.22M | -189.02M |
| Cash from Operations | -89.40M | -81.70M | -100.20M | -170.04M | -274.67M |
| Capital Expenditure | -32.37M | -34.07M | -28.57M | -18.58M | -15.64M |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 362.86M | 319.06M | 738.16M | 1.78M | 347.92M |
| Cash from Investing | 330.49M | 284.99M | 709.59M | -16.80M | 332.28M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -47.76M | -4.06M | -3.56M | -3.52M | -4.08M |
| Issuance of Common Stock | 214.28M | 1.98M | 3.28M | 3.56M | 7.70M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 166.52M | -2.08M | -277.00K | 39.00K | 3.61M |
| Foreign Exchange rate Adjustments | -1.24M | 3.46M | 6.06M | 6.35M | 4.03M |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 406.36M | 204.66M | 615.16M | -180.46M | 65.26M |